FDA alerts clinicians about fake Botox
Unapproved versions of onabotulinumtoxinA (Botox, Allergan) sent by foreign suppliers has prompted the
Food and Drug Administration to issue alerts to more than 350 medical practices that may have purchased the
products.
Source: Modern Medicine - Category: Journals (General) Source Type: news